Thurston, Springer, Miller, Herd & Titak, Inc. Assertio Holdings, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $475 Million
- Q4 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 67,500 shares of ASRT stock, worth $55,350. This represents 0.01% of its overall portfolio holdings.
Number of Shares
67,500
Previous 50,500
33.66%
Holding current value
$55,350
Previous $59,000
1.69%
% of portfolio
0.01%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ASRT
# of Institutions
97Shares Held
31MCall Options Held
957KPut Options Held
38.5K-
Nantahala Capital Management, LLC New Canaan, CT8.95MShares$7.34 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$3.67 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.23MShares$2.65 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.39MShares$1.14 Million0.0% of portfolio
-
Aqr Capital Management LLC Greenwich, CT1.26MShares$1.03 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $39.5M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...